Skip to main content
Journal cover image

Measuring the severity of topical 5-fluorouracil toxicity.

Publication ,  Journal Article
Korgavkar, K; Firoz, EF; Xiong, M; Lew, R; Marcolivio, K; Burnside, N; Dyer, R; Weinstock, MA; VAKCC Trial Group,
Published in: J Cutan Med Surg
2014

BACKGROUND: Topical 5% 5-fluorouracil (5-FU) is known to cause toxicity, such as erythema, pain, and crusting/erosions. OBJECTIVES: We sought to develop a scale to measure this toxicity and test the scale for reliability. METHODS: A scale was developed involving four parameters: erythema severity, percentage of face involved in erythema, crusting/erosions severity, and percentage of face involved in crusting/erosions. Thirteen raters graded 99 sets of photographs from the Veterans Affairs Keratinocyte Carcinoma Chemoprevention (VAKCC) Trial using these parameters. RESULTS: Intraclass correlation overall for 13 raters was 0.82 (95% CI 0.77-0.86). There was no statistically significant trend in reliability by level of training in dermatology. CONCLUSIONS: This scale is a reliable method of evaluating the severity of toxicity from topical 5-fluorouracil and can be used by dermatologists and nondermatologists alike.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Cutan Med Surg

DOI

ISSN

1203-4754

Publication Date

2014

Volume

18

Issue

4

Start / End Page

229 / 235

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Severity of Illness Index
  • Reproducibility of Results
  • Observer Variation
  • Middle Aged
  • Male
  • Humans
  • Fluorouracil
  • Female
  • Facial Dermatoses
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Korgavkar, K., Firoz, E. F., Xiong, M., Lew, R., Marcolivio, K., Burnside, N., … VAKCC Trial Group, . (2014). Measuring the severity of topical 5-fluorouracil toxicity. J Cutan Med Surg, 18(4), 229–235. https://doi.org/10.2310/7750.2013.13143
Korgavkar, Kaveri, Elnaz F. Firoz, Michael Xiong, Robert Lew, Kimberly Marcolivio, Nancy Burnside, Robert Dyer, Martin A. Weinstock, and Martin A. VAKCC Trial Group. “Measuring the severity of topical 5-fluorouracil toxicity.J Cutan Med Surg 18, no. 4 (2014): 229–35. https://doi.org/10.2310/7750.2013.13143.
Korgavkar K, Firoz EF, Xiong M, Lew R, Marcolivio K, Burnside N, et al. Measuring the severity of topical 5-fluorouracil toxicity. J Cutan Med Surg. 2014;18(4):229–35.
Korgavkar, Kaveri, et al. “Measuring the severity of topical 5-fluorouracil toxicity.J Cutan Med Surg, vol. 18, no. 4, 2014, pp. 229–35. Pubmed, doi:10.2310/7750.2013.13143.
Korgavkar K, Firoz EF, Xiong M, Lew R, Marcolivio K, Burnside N, Dyer R, Weinstock MA, VAKCC Trial Group. Measuring the severity of topical 5-fluorouracil toxicity. J Cutan Med Surg. 2014;18(4):229–235.
Journal cover image

Published In

J Cutan Med Surg

DOI

ISSN

1203-4754

Publication Date

2014

Volume

18

Issue

4

Start / End Page

229 / 235

Location

United States

Related Subject Headings

  • Skin Neoplasms
  • Severity of Illness Index
  • Reproducibility of Results
  • Observer Variation
  • Middle Aged
  • Male
  • Humans
  • Fluorouracil
  • Female
  • Facial Dermatoses